NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announces its consolidated half-year financial results and provides updates on key ...

Republican Doug Ose, a politically moderate former congressman from the Sacramento region who last year became one of President Donald Trump’s most vociferous surrogates in California, on Friday ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnémo: OSE) announces the presentation of Phase 3 clinical results of Tedopi® today at 13:30 ...

OSE Immunotherapeutics is hoping to show Servier what they walked away from. Around one year after the French drugmakers split up, the biotech has reported midphase data on an anti-IL-7 antibody ...

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis Lusvertikimab ...

NANTES, France, April 16, 2024 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage immunotherapy company, today announced that the Hart-Scott-Rodino waiting period has ...

NANTES, France - March 26, 2025, 6:15 p.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and ...

OSE-230 was developed to activate a unique mechanism for resolving chronic inflammation, focusing on modulation of macrophages and neutrophils. AbbVie and OSE Immunotherapeutics announced that they ...

Osé, the sex toy that received a CES Innovation Award, lost it, and then won it back again, is finally ready to pre-order. The device sparked a debate about gender bias in the tech industry and what ...

When budget constraints forced the closure of Gibson Ranch Park in Sacramento County four years ago, Doug Ose, a land developer long back from a stint in Congress, applied to run the facility as a ...